<DOC>
	<DOCNO>NCT01544972</DOCNO>
	<brief_summary>The purpose study determine oral paracetamol ibuprofen efficacy safety relation serum level closure patent ductus arteriosus preterm infant .</brief_summary>
	<brief_title>Serum Level Measurement Oral Paracetamol Oral Ibuprofen Patent Ductus Arteriosus Treatment Preterm Infants</brief_title>
	<detailed_description>To determine oral paracetamol ibuprofen efficacy safety relation serum level closure patent ductus arteriosus preterm infant . Eighty preterm infant patent ductus arteriosus enrol prospective-randomized study . Patients receive oral ibuprofen initial dose 10 mg/kg , follow 5 mg/kg 24 48 h oral paracetamol 15 mg/kg per dose every 6 hour 3 day . One follow echocardiographic criterion duct size &gt; 1.5 mm , leave atrium-to-aorta ratio &gt; 1.5 , left-to-right shunting blood , end diastolic reversal blood flow aorta , poor cardiac function addition sign patent ductus arteriosis determine need treatment . Three consecutive blood sample infant 3 day dose application drug ( ibuprofen paracetamol obtain . The relation pharmacokinetics drug drug response evaluate</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Birth weight 1250 gram Diagnosed patent ductus arteriosus Echocardiographic examination Accompanied congenital cardiac anomaly Severe thrombocytopenia &lt; 60.000 Severe intracranial bleeding ( Grade III IV ) Intestinal abnormality necrotising enterocolitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Patent Ductus Arteriosus</keyword>
	<keyword>Paracetamol</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Serum level</keyword>
	<keyword>Preterm infant</keyword>
</DOC>